HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

ZD 4190

VEGF receptor antagonist; structure in first source
Also Known As:
N-(4-bromo-2-fluorophenyl)-6-methoxy-7-(2-(1H-1,2,3-triazol-1-yl)ethoxy)quinazolin-4-amine; ZD-4190; ZD4190
Networked: 8 relevant articles (1 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Wedge, Stephen R: 2 articles (01/2009 - 06/2003)
2. Wedge, S R: 2 articles (10/2003 - 02/2000)
3. Kiesewetter, Dale: 1 article (07/2011)
4. Sun, Xilin: 1 article (07/2011)
5. Lang, Lixin: 1 article (07/2011)
6. Niu, Gang: 1 article (07/2011)
7. Chen, Xiaoyuan: 1 article (07/2011)
8. Yan, Yongjun: 1 article (07/2011)
9. Gao, Haokao: 1 article (07/2011)
10. Quan, Qimeng: 1 article (07/2011)

Related Diseases

1. Neoplasms (Cancer)
2. Carcinoma (Carcinomatosis)
3. Colonic Neoplasms (Colon Cancer)

Related Drugs and Biologics

1. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
2. Protein-Tyrosine Kinases (Tyrosine Kinase)
3. Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
4. Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
5. Semaphorins (Semaphorin)
6. Cisplatin (Platino)
7. AH 111585
8. N- (2- chloro- 5- methoxyphenyl)- 6- methoxy- 7- ((1- methyl- 4- piperidinyl) methoxy) 4-quinazolinamine
9. contrast agent P792

Related Therapies and Procedures

1. Oral Administration
2. Heterologous Transplantation (Xenotransplantation)